According to IQVIA™, U.S. market annual sales for the 12 months ended December 2022 for Metronidazole Gel USP, 1% is estimated to be approximately $17 million.

For 60 gm tube of metronidazole gel USP 1% import item allowed: 0.612 gm of micronized metronidazole USP per pack. This is aimed to bring clarity and facilitate ease in the manufacturing and export of ...

According to IQVIA, Metronidazole Gel, USP 1 per cent, has an estimated market size of USD 29 million for twelve months ending June 2021, Alembic Pharma said.

HAWTHORNE, N.Y., July 18, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that it has received approval from the U.S. Food and Drug Administration for its ...

SAN FRANCISCO (MarketWatch) -- Taro Pharmaceutical Industries Ltd. Tuesday said the Food and Drug Administration has approved its abbreviated new drug application for Metronidazole Topical Gel USP ...

DUBLIN and LAVAL, Quebec — Actavis and Valeant Pharmaceuticals International announced that the Food and Drug Administration approved the new drug application for Metronidazole 1.3% vaginal gel.

Launch Expands Cosette’s Generic Portfolio Through Organic Development. BRIDGEWATER, N.J.--(BUSINESS WIRE)--#RandD--Cosette Pharmaceuticals, Inc. ("Cosette") announced that the U.S. Food and Drug ...

According to IQVIA, Metronidazole Gel, USP 1 percent, has an estimated market size of USD 29 million for twelve months ending June 2021, Alembic Pharma said.

Drug firm Alembic Pharmaceuticals on Monday said its joint venture Aleor Dermaceuticals has received approval from the US health regulator for generic Metronidazole gel, used in the treatment of ...